The
Global
Clinical Laboratory Services Market was
valued US$ 168.9 billion in 2015 and is projected to expand at a CAGR
of 7.3% during the forecast period (2016-2024), as analyzed by
Coherent Market Insights in a detailed report about the same.
Increasing health consciousness leading to higher preventive
measures, especially in Asia Pacific region, would be a major factor
for increasing demand of the clinical laboratory services market.
Increasing insurance coverage is further propelling adoption of
diagnostic testing and in turn favors growth of clinical laboratory
services market.
In order to capitalize on this highly lucrative
opportunity, clinical laboratory service providers such as Laboratory
Corporation of America Holdings (LabCorp), Quest Diagnostics, Inc.,
Spectra Laboratories, Sonic Healthcare Limited, and Charles River
Laboratories are offering additional services such as web-based
booking of test/service and free home pick-up of test samples,
complementing regular packages for health check-ups. Charles River
Laboratories International, Inc., analyzes samples for metabolic
disorders, bone therapy, diabetes and oncology. Globally too,
clinical laboratories receive large volumes of samples for analyzing
metabolic disorders. The market for clinical chemistry test types is
therefore positioned on a strong growth trajectory.
Fill the form for an exclusive sample of this
report :
https://www.coherentmarketinsights.com/insight/request-sample/87
Increasing competition among clinical laboratory
service providers in turn is leading to rampant increase in industry
consolidation and vertical/horizontal integration. Companies are
focusing on establishing regional supremacy in turn improving the
dynamics of clinical laboratory services market.
-
For instance, Laboratory Corporation of America Holdings (LabCorp) acquired Sequenom, Inc. in July 2016, subsequently becoming the leader in non-invasive prenatal testing (NIPT) for reproductive health. The company continues its inorganic growth roadmap and in October 2016, it acquired ClearPath Diagnostics, a leading clinical laboratory service provider in the Northeastern region of the U.S.
-
In November 2016, Sonic Healthcare Limited increased its ownership stake in GLP Systems from 25% to 80%. GLP Systems, a Germany-based company, developed an innovative laboratory automation technology that enables seamless and automated transportation of specimen tubes between storage, work areas, and diagnostic machines.
-
Furthermore, Sonic Healthcare Limited also expanded its presence in Germany by acquiring Staber Laboratory Group based in Munich, Germany, in November 2016. The Staber Group has three hub laboratories and 14 regional, specialty and hospital labs in Germany, making it one of the leading players in the country.
Increasing incidence of infectious diseases and
the growing burden of non-communicable diseases is in turn driving
demand for clinical tests. This is influencing clinical laboratory
service providers to increase their functional capabilities to cater
to the growing needs of patients. As mentioned by Quest Diagnostics,
Inc., around 70% of the medical decision are based on lab results. In
addition, genetic and cytology testing is increasing that enable
better diagnosis of cancer. This is expected to proliferate demand
and spur growth for clinical laboratory services market in emerging
economies such as China and India. Core Diagnostics, Metropolis, SRL
Diagnostics and Dr. Lal Pathlabs are few major diagnostic service
providers in India expanding at a rapid pace.
Clinical laboratory service providers are thus,
upgrading their processes and technologies to improve efficiency.
Therefore, equipment manufacturers such as Abbott Laboratories, Roche
and ThermoFisher Scientific also need to develop products catering to
this evolving market. Seamless integration of equipment manufacturer
and service provider technologies would be a great boost for the
global clinical laboratory services market.
Get discount on sample copy :
https://www.coherentmarketinsights.com/insight/request-discount/87
Key takeaways of the market:
-
The global clinical laboratory services market is estimated to be valued at US$ 192.3 billion in 2017. Growing aging population and increasing incidence of infectious diseases, cardiac disorders, stroke, and liver disorders are factors attributed to growing number of patients visiting clinical laboratories to undergo preventive tests
-
Clinical chemistry test was the dominant segment in the global clinical laboratory services market, accounting for more than 40% of total revenue share in 2015. Clinical chemistry test includes testing of blood and urine samples in the patients as an initial step to diagnose a disease or preexisting health condition.
-
Among service providers, the hospital-based clinical laboratories segment generated the highest revenue in 2015. This is owing to availability of better diagnostic devices and services in hospitals as compared to other healthcare service providers.
-
However, the services offered by standalone clinical laboratories are improving rapidly, wherein accessibility to patients has increased
-
The clinical laboratory services market is expected to gain significant growth traction in Asia Pacific and Latin America, mainly attributed to high prevalence of infectious and non-communicable diseases, increasing health concerns, and new diagnostic laboratories being established to cater to the growing needs of patient for health check-ups
Consolidation is the key trend observed in order
to cement the market presence and sustain the customer base - LabCorp
acquired Sequenom, Inc in July 2016, and ClearPath Diagnostics in
October 2016
About Coherent Market Insights:
Coherent Market Insights is a prominent market
research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
E-mail:sales@coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
E-mail:sales@coherentmarketinsights.com
No comments:
Post a Comment